Provident Financial Holdings, Inc. (PROV) Q2 2026 Earnings Call Transcript

1 min read
325 views

Operator

Ladies and gentlemen, thank you for standing by. My name is Colby, and I’ll be your conference operator today. At this time, I’d like to welcome you to the Provident Financial Holdings’ Second Quarter of Fiscal 2026 Earnings Call. [Operator Instructions]

I will now turn the call over to Donavon Ternes, President and CEO. You may begin.

Donavon Ternes
President & CEO

Thank you, Colby. Good morning. This is Donavon Ternes, President and CEO of Provident Financial Holdings. And on the call with me is Peter Fan, our Senior Vice President and Chief Financial Officer. Before we begin, I have a brief administrative item to address.

Our presentation today discusses the company’s business outlook and will include forward-looking statements. Those statements include descriptions of management’s plans, objectives or goals for future operations, products or services, forecasts of financial or other performance measures and statements about the company’s general outlook for interest rates, economic and business conditions. We also may make forward-looking statements during the question-and-answer period following management’s presentation. These forward-looking statements are subject to a number of risks and uncertainties, and actual results may differ materially from those discussed today.

Information on the risk factors that could cause actual results to differ from any forward-looking statement is available from the earnings release that was distributed yesterday, from the annual report on Form 10-K for the year ended June 30, 2025, and from the Form 10-Qs and other SEC filings that are filed subsequent to the Form 10-K. Forward-looking statements are effective only as of the date that they are made, and the company assumes no

Read the full article here

Leave a Reply

Your email address will not be published.

Previous Story

AGF Management Limited (AGF.B:CA) Q4 2025 Earnings Call Transcript

Next Story

AgomAb Therapeutics NV Readies US IPO On Early Promising Results (AGMB)

Latest from News